Ramsay Générale de Santé
France · FR0000044471 · reports in EUR · Europe
Four figures
From the annual report for the year to Jun 30, 2026. Each line says what it is based on.
- Revenue growth
- Revenue +3.3% in the year to Jun 30, 2026, on the year before.
- Return on equity
- It earned −4.3% on its shareholders' equity in the year to Jun 30, 2026.
- Equity and assets
- Equity is 17% of its assets, and operations brought in cash in the year.
- Price and earnings
- Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.
The year
Year to Jun 30, 2026, consolidated, in EUR.
€5.4B
revenue
3.5%
operating margin
−€48M
net profit
Year by year
As filed; an earlier year can differ from its own report when the company restated it.
| Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 | |
|---|---|---|---|---|
| Revenue | €4.7B | €5.0B | €5.2B | €5.4B |
| Operating profit | €240M | €161M | €173M | €186M |
| Net profit to shareholders | €49M | −€54M | −€54M | −€48M |
| Earnings per share | €0.45 | −€0.49 | −€0.49 | −€0.44 |
| Dividend per share | €0.00 | n/a | n/a | €0.00 |
| Cash from operations | €599M | €587M | €694M | €525M |
| Cash | €352M | €359M | €367M | €302M |
| Total assets | €7.0B | €6.9B | €6.8B | €6.7B |
| Equity | €1.3B | €1.2B | €1.2B | €1.2B |
What they do
In the company's own words, from the annual report.
exerce la totalité de ses activités dans le secteur Soins et Services Hospitaliers
Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the ratios from the filed figures.